Cargando…

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth

Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. Cetuximab, a human/mouse chimeric monoclonal antibody, is effective in a limited number of CRC patients because of cetuximab resistance. This study aimed to identify novel therapeutic targets in cetuximab-resistant CRC i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeoung, Mee Hyun, Kim, Taek-Keun, Kim, Ji Woong, Cho, Yea Bin, Na, Hee Jun, Yoo, Byong Chul, Shim, Hyunbo, Song, Dong-Keun, Heo, Kyun, Lee, Sukmook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920916/ https://www.ncbi.nlm.nih.gov/pubmed/31683810 http://dx.doi.org/10.3390/biom9110681

Ejemplares similares

Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
por: Kim, Ji Woong, et al.
Publicado: (2021)

Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

Visualization of conformational transition of GRP94 in solution
por: Sun, Shangwu, et al.
Publicado: (2023)

A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro
por: Kim, Mi Ra, et al.
Publicado: (2017)

Differential requirement of GRP94 and GRP78 in mammary gland development
por: Zhu, Genyuan, et al.
Publicado: (2014)

The clinical and prognostic evaluation of GRP94 immunoexpression in Caucasian patients with colorectal adenocarcinoma
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2019)

GRP94 (gp96) and GRP94 N-Terminal Geldanamycin Binding Domain Elicit Tissue Nonrestricted Tumor Suppression
por: Baker-LePain, Julie C., et al.
Publicado: (2002)

Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions
por: Pagetta, Andrea, et al.
Publicado: (2014)

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)

CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis
por: Jang, Jihye, et al.
Publicado: (2017)

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a
por: Kim, Taek‐Keun, et al.
Publicado: (2018)

Co-downregulation of GRP78 and GRP94 Induces Apoptosis and Inhibits Migration in Prostate Cancer Cells
por: Lu, Tong, et al.
Publicado: (2019)

GRP & love 94 present cool jazz and smooth vocals
Publicado: (1993)

Exploring the Functional Complementation between Grp94 and Hsp90
por: Maharaj, Kevin A., et al.
Publicado: (2016)

GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells
por: Santana-Codina, Naiara, et al.
Publicado: (2019)

Upregulation of Phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in Acquired Middle Ear Cholesteatoma Growth
por: Ho, Kuen Yao, et al.
Publicado: (2013)

Targeted Deletion of ER Chaperone GRP94 in the Liver Results in Injury, Repopulation of GRP94-Positive Hepatocytes, and Spontaneous Hepatocellular Carcinoma Development in Aged Mice
por: Chen, Wan-Ting, et al.
Publicado: (2014)

Glucose-Regulated Protein 94 (GRP94): A Novel Regulator of Insulin-Like Growth Factor Production
por: Argon, Yair, et al.
Publicado: (2020)

OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation
por: Dersh, Devin, et al.
Publicado: (2014)

TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
por: Heo, Kyun, et al.
Publicado: (2020)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Comprehensive analysis reveals GRP94 is associated with worse prognosis of breast cancer
por: Wang, Ting, et al.
Publicado: (2021)

Grp94 Inhibitor HCP1 Inhibits Human Dermal Fibroblast Senescence
por: Cui, Xiaoling, et al.
Publicado: (2022)

Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
por: Langer, Rupert, et al.
Publicado: (2008)

Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells
por: Nami, Babak, et al.
Publicado: (2016)

Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients
por: Park, Jin Hyun, et al.
Publicado: (2022)

Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells
por: Pizzo, Paola, et al.
Publicado: (2010)

The endoplasmic reticulum chaperone BiP is a closure-accelerating cochaperone of Grp94
por: Huang, Bin, et al.
Publicado: (2022)

Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis
por: Choi, YunJeong, et al.
Publicado: (2020)

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma
por: Sabbatino, F, et al.
Publicado: (2015)

Decreased functional expression of Grp78 and Grp94 inhibits proliferation and attenuates apoptosis in a human gastric cancer cell line in vitro
por: ZHANG, XINCHEN, et al.
Publicado: (2015)

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
por: Shim, Hyunbo
Publicado: (2020)

Synthetic approach to the generation of antibody diversity
por: Shim, Hyunbo
Publicado: (2015)

Hepatic Overexpression of GRP94 in a Rabbit Model of Parenteral Nutrition-Associated Liver Disease
por: Zhu, Xueping, et al.
Publicado: (2015)

Overexpression of molecule GRP94 favors tumor progression in lung adenocarcinoma by interaction with regulatory T cells
por: Duan, Xiao‐Feng, et al.
Publicado: (2020)

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
por: Niu, Mengmeng, et al.
Publicado: (2021)

Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab
por: Sun, Chaonan, et al.
Publicado: (2017)

Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of glucose-regulated protein94 (Grp94)-IgG complexes
por: Tramentozzi, Elisa, et al.
Publicado: (2011)

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis
por: Kim, Taek-Keun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hu8n1ctcnkonbf7is48mo8ot94